Evidence map›Paper›PMID 24448570›Full record

ReviewNature immunology2014

Single-cell technologies for monitoring immune systems.

Pratip K Chattopadhyay, Todd M Gierahn, Mario Roederer, J Christopher Love

Abstract readReview
In one paragraph

Review in Nature immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Cell-Based Immuno-Biosensors Using Microfluidics.Sensors (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Applicability of Spatial Technology in Cancer Research.Cancer research and treatment · 2024
    Review
  16. Probing T-cell activation in nanoliter tumor co-cultures using membrane displacement trap arrays.Integrative biology : quantitative biosciences from nano to macro · 2024
    Article
  17. Article
  18. Review
  19. Deciphering Cell-Cell Interactions with Integrative Single-Cell Secretion Profiling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pratip K ChattopadhyayImmunoTechnology Section, Vaccine Research Center, NIAID, National Institutes of Health, Bethesda, Maryland, USA.
Todd M GierahnKoch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Mario RoedererImmunoTechnology Section, Vaccine Research Center, NIAID, National Institutes of Health, Bethesda, Maryland, USA.
J Christopher LoveKoch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
Systems investigation of vaccine responses in B cell depleted autoimmune patientsU19AI089992 · NIAID · YALE UNIVERSITY · PI David A. Hafler, RUTH R MONTGOMERY · 2010 to 2026
$50.4M
Functional And Phenotypic Characterization Of T Cells In ManZIAAI005021 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ROEDERER, MARIO · 2009 to 2022
$14.4M
Development Of Flow Cytometric Technologies For Immune AssaysZIAAI005020 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ROEDERER, MARIO · 2009 to 2019
$9.6M
Impact of MHC Genotype on Ex Vivo T cell Function in Type 1 DiabetesDP3DK097681 · NIDDK · DANA-FARBER CANCER INST · PI LOVE, JOHN CHRISTOPHER, WUCHERPFENNIG, KAI W · 2012 to 2012
$3.9M
Highly Multiplexed Single-cell Transcript Analysis Using DNA-barcoded NanowellsR21AI106025 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LOVE, JOHN CHRISTOPHER · 2012 to 2013
$408k
Nanowell-based single-cell technology for characterizing clinical samples ex vivoR56AI104274 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LOVE, JOHN CHRISTOPHER · 2012 to 2012
$406k
NCI NIH HHS P30 CA014051NIAID NIH HHS 1R56AI104274NIAID NIH HHS 1U19AI089992NIAID NIH HHS 5R21AI106025NIAID NIH HHS R21 AI106025NIAID NIH HHS R56 AI104274NIAID NIH HHS U19 AI089992NIDDK NIH HHS DP3 DK097681
6 · The paper itself

Abstract

The complex heterogeneity of cells, and their interconnectedness with each other, are major challenges to identifying clinically relevant measurements that reflect the state and capability of the immune system. Highly multiplexed, single-cell technologies may be critical for identifying correlates of disease or immunological interventions as well as for elucidating the underlying mechanisms of immunity. Here we review limitations of bulk measurements and explore advances in single-cell technologies that overcome these problems by expanding the depth and breadth of functional and phenotypic analysis in space and time. The geometric increases in complexity of data make formidable hurdles for exploring, analyzing and presenting results. We summarize recent approaches to making such computations tractable and discuss challenges for integrating heterogeneous data obtained using these single-cell technologies.

Indexed as

Immunologic TechniquesAnimalsComputational BiologyHumansImmune SystemMonitoring, ImmunologicSingle-Cell AnalysisStatistics as Topic

Identifiers

PMID24448570
PMCPMC4040085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.